Randomized, Double Blind, Cross-over Study to Evaluate the Safety and Efficacy of CNV1014802 in Subjects With Neuropathic Pain From Lumbosacral Radiculopathy.
Phase of Trial: Phase II
Latest Information Update: 17 Oct 2017
At a glance
- Drugs Raxatrigine (Primary)
- Indications Neuropathic pain
- Focus Proof of concept; Therapeutic Use
- Sponsors Convergence Pharmaceuticals
- 23 Sep 2014 Primary endpoint has been met (pain intensity measured by the Numerical Rating Scale), as reported in a Convergence Pharmaceuticals media release.
- 23 Sep 2014 Results published in a Convergence Pharmaceuticals media release.
- 01 Aug 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History